Post-Marketing Observational Study of Safety Following Vaccination With Flublok® Compared to Licensed IIV in Adults

Clinical trial NCT02600585 · COMPLETED

Trial details

NCT number: NCT02600585
Sponsor: Protein Sciences Corporation
Status: COMPLETED
Study type: OBSERVATIONAL

Human Influenza

Start date: 2015-11-01
Primary completion: 2016-09-01
Enrollment: 254648

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.